Literature DB >> 14505638

Combinatorial modification of natural products: synthesis and in vitro analysis of derivatives of thiazole peptide antibiotic GE2270 A: A-ring modifications.

Jeffrey Clough1, Shaoqing Chen, Eric M Gordon, Corinne Hackbarth, Stuart Lam, Joaquim Trias, Richard J White, Gianpaolo Candiani, Stefano Donadio, Gabriella Romanò, Romeo Ciabatti, Jeffrey W Jacobs.   

Abstract

Thiazole peptide GE2270 A (1) possesses potent antimicrobial activity against many gram-positive pathogens, including methicillin resistant Staphylococcus aureus (S. aureus, MRSA; MIC(90)=0.06 microg/mL) and vancomycin resistant Enterococcus spp. (VRE; MIC(90)=0.03 microg/mL); however its poor aqueous solubility has prohibited its development for the clinical treatment of infections. An integrated combinatorial and medicinal chemistry program was employed to identify derivatives of 1 that retain activity but possess greatly enhanced aqueous solubility.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14505638     DOI: 10.1016/s0960-894x(03)00811-4

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  In vitro and in vivo activities of novel, semisynthetic thiopeptide inhibitors of bacterial elongation factor Tu.

Authors:  J A Leeds; M J LaMarche; J T Brewer; S M Bushell; G Deng; J M Dewhurst; J Dzink-Fox; E Gangl; A Jain; L Lee; M Lilly; K Manni; S Mullin; G Neckermann; C Osborne; D Palestrant; M A Patane; A Raimondi; S Ranjitkar; E M Rann; M Sachdeva; J Shao; S Tiamfook; L Whitehead; D Yu
Journal:  Antimicrob Agents Chemother       Date:  2011-08-08       Impact factor: 5.191

2.  Experimental spectral characterization, Hirshfeld surface analysis, DFT/TD-DFT calculations and docking studies of (2Z,5Z)-5-(4-nitrobenzylidene)-3-N(2-methoxyphenyl)-2-N'(2-methoxyphenylimino) thiazolidin-4-one.

Authors:  Ahmed Djafri; Fouzia Perveen; Nadia Benhalima; Nawel Khelloul; Rachida Rahmani; Ayada Djafri; Abdelkader Chouaih; Mohammed Benali Kanoun; Souraya Goumri-Said
Journal:  Heliyon       Date:  2020-12-22

3.  QSAR and Molecular Docking Studies of Pyrimidine-Coumarin-Triazole Conjugates as Prospective Anti-Breast Cancer Agents.

Authors:  Arun Kumar Subramani; Amuthalakshmi Sivaperuman; Ramalakshmi Natarajan; Richie R Bhandare; Afzal B Shaik
Journal:  Molecules       Date:  2022-03-11       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.